HLA class II antibodies in the treatment of hematologic malignancies.

HLA class II antibodies in the treatment of hematologic malignancies.

Item
http://www.wikidata.org/entity/Q35206356
Targeted Radionuclide Therapy of Human TumorsA humanized HLA-DR antibody (hu1D10, apolizumab) in combination with granulocyte colony-stimulating factor (filgrastim) for the treatment of non-Hodgkin's lymphoma: a pilot studyEmerging drugs for chronic lymphocytic leukaemia.A recombinant bispecific single-chain Fv antibody against HLA class II and FcgammaRIII (CD16) triggers effective lysis of lymphoma cells.Combating non-Hodgkin lymphoma by targeting both CD20 and HLA-DR through CD20-243 CrossMabAntitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia.Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomasCharacterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximabStructurally Defined αMHC-II Nanobody-Drug Conjugates: A Therapeutic and Imaging System for B-Cell Lymphoma.A bispecific antibody directly induces lymphoma cell death by simultaneously targeting CD20 and HLA-DR.Fully human antibody exhibits pan-human leukocyte antigen-DR recognition and high in vitro/vivo efficacy against human leukocyte antigen-DR-positive lymphomas.Radioimmunotherapy of non-Hodgkin's lymphoma: a critical appraisal.Defective class II transactivator expression in a B lymphoma cell line.
P2860

HLA class II antibodies in the treatment of hematologic malignancies.

Item
http://www.wikidata.org/entity/Q35206356
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
HLA class II antibodies in the treatment of hematologic malignancies.
@ast
HLA class II antibodies in the treatment of hematologic malignancies.
@en
type
label
HLA class II antibodies in the treatment of hematologic malignancies.
@ast
HLA class II antibodies in the treatment of hematologic malignancies.
@en
prefLabel
HLA class II antibodies in the treatment of hematologic malignancies.
@ast
HLA class II antibodies in the treatment of hematologic malignancies.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
HLA class II antibodies in the treatment of hematologic malignancies.
@en
P2093
P304
P31
P356
10.1016/S0093-7754(03)00252-5
P433
P478
P577
P698